Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
May 1, 2026
UM School of Medicine doctors at the University of Maryland Medical Center Treat 41-Year-Old patient with her own genetically modified stem cells in a promising chance for a cure.
